Steven P. Coen is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 7,288 shares of DNA, which is worth approximately $71,276. The most recent transaction as insider was on Jan 06, 2025, when has been sold 324 shares (Class A Common Stock) at a price of $11.72 per share, resulting in proceeds of $3,797. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.29K
20.54% 3M change
n/a 12M change
Total Value Held $71,276

Steven P. Coen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
SELL
Open market or private sale
$3,797 $11.72 p/Share
324 Reduced 4.26%
7,288 Class A Common Stock
Jan 03 2025
BUY
Exercise of conversion of derivative security
-
743 Added 8.89%
7,612 Class A Common Stock
Dec 04 2024
SELL
Open market or private sale
$3,181 $9.64 p/Share
330 Reduced 4.58%
6,869 Class A Common Stock
Dec 03 2024
BUY
Exercise of conversion of derivative security
-
743 Added 9.36%
7,199 Class A Common Stock
Nov 04 2024
SELL
Open market or private sale
$2,524 $7.58 p/Share
333 Reduced 4.9%
6,456 Class A Common Stock
Nov 01 2024
BUY
Exercise of conversion of derivative security
-
743 Added 9.86%
6,789 Class A Common Stock
Oct 04 2024
SELL
Open market or private sale
$2,555 $8.35 p/Share
306 Reduced 4.82%
6,046 Class A Common Stock
Oct 03 2024
BUY
Exercise of conversion of derivative security
-
743 Added 10.47%
6,352 Class A Common Stock
Sep 12 2024
SELL
Open market or private sale
$1,949 $6.17 p/Share
316 Reduced 5.33%
5,609 Class A Common Stock
Sep 11 2024
BUY
Exercise of conversion of derivative security
-
743 Added 11.14%
5,925 Class A Common Stock
Aug 02 2024
SELL
Open market or private sale
$5,070 $0.29 p/Share
17,486 Reduced 7.78%
207,318 Class A Common Stock
Aug 01 2024
BUY
Exercise of conversion of derivative security
-
29,746 Added 11.69%
224,804 Class A Common Stock
Jul 02 2024
SELL
Open market or private sale
$4,461 $0.33 p/Share
13,520 Reduced 6.48%
195,058 Class A Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
-
29,746 Added 12.48%
208,578 Class A Common Stock
Jun 03 2024
SELL
Open market or private sale
$7,392 $0.55 p/Share
13,440 Reduced 6.99%
178,832 Class A Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
29,745 Added 13.4%
192,272 Class A Common Stock
May 02 2024
SELL
Open market or private sale
$110,819 $0.84 p/Share
131,928 Reduced 44.8%
162,527 Class A Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
294,455 Added 50.0%
294,455 Class A Common Stock
SPC

Steven P. Coen

Officer
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA